Altitude Life Science Ventures

Altitude Life Science Ventures is a venture capital firm that focuses on investing in early-stage life science companies within markets exhibiting significant demand and growth potential. The firm seeks to back high-quality teams to build strong, defensible, and long-term businesses. Their investment scope extends beyond prescription drugs to include any commercial application of proprietary technology originating from key advances in biology or chemistry, such as therapeutics, diagnostics, gene editing, AI/machine learning therapeutics, medical devices, aesthetic and medical dermatology, drug delivery platforms, industrial/chemical reactions, and DNA sequencing.

The firm's investment strategy is differentiated by its emphasis on intellectual property (IP) strategic planning. This approach integrates the fundamental activities of early-stage life science companies with the creation, development, and presentation of the company's IP portfolio on a worldwide basis. Critical to IP strategic planning is the development of multiple levels of protection to complement the maturation of the company and development of the technology, confirm competitive advantages, preserve near and long-term product opportunities, complement research and development activities, support business development activities, and maximize both the perceived and demonstrated value of the company's technology.

Altitude Life Science Ventures is headquartered in Kirkland, Washington, and operates with a team dedicated to identifying and nurturing promising life science startups. Their focus on IP strategic planning is essential to maximize and preserve the value of early-stage life science companies as they mature and develop identifiable commercial assets.